Amalgamated Financial’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Amalgamated Financial’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$5.87M	Buy	+72,446	New	+$6.13M	0.05%	381

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Amalgamated Financial's SYNH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022: 72,446 shares worth $5.87M. The stake represents 0.05% of the portfolio and ranks #381 among its holdings.

366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

Amalgamated Financial held 72,446 shares of Syneos Health, Inc. Class A Common Stock worth $5.87M as of Q1 2022.
Syneos Health, Inc. Class A Common Stock was a new Amalgamated Financial position in Q1 2022.
Syneos Health, Inc. Class A Common Stock made up 0.05% of Amalgamated Financial's portfolio in Q1 2022, its #381 holding.
366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.